During the past decade, JSS Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "JSS Hospital" #1 sponsor was "Clearside Biomedical, Inc." with 2 trials, followed by "Apogenix AG" with 1 trials sponsored, "Asahi Kasei Pharma America Corporation" with 1 trials sponsored, "BerGenBio ASA" with 1 trials sponsored and "Dr. Reddy's Laboratories Limited" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "JSS Hospital" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "CRO: JSS Medical Research India Pvt. Ltd." with 1 trials as a collaborator, "Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation" with 1 trials as a collaborator and "Indian Society of Critical Care Medicine" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "JSS Hospital" are "COVID-19" (2 trials), "Panuveitis" (2 trials), "Uveitis" (2 trials), "Uveitis, Anterior" (2 trials) and "Uveitis, Intermediate" (2 trials). Many other conditions were trialed in "JSS Hospital" in a lesser frequency.

Most popular intervention types in "JSS Hospital" are "Drug" (7 trials), "Other" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "4 mg CLS-TA Suprachoriodal Injection" (1 trials), "4mg CLS-TA Suprachoriodal Injection" (1 trials), "ART-123" (1 trials) and "ATM-AVI" (1 trials). Other intervention names were less common.

The vast majority of trials in "JSS Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "JSS Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in JSS Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in JSS Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

JSS Hospital has several departments that took part in Clinical trials: "JSS Medical College and Hospital - Dept of Psychiatry" - 2 trials